Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ExpreS2ion Announces Formation of Oncology Scientific Advisory Board

Hørsholm, Denmark, November 3, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") today announces the establishment of an Oncology Scientific Advisory Board (OSAB). The six initial members of the ExpreS2ion OSAB bring a depth of knowledge in oncology, breast cancer, clinical trials and therapeutic HER2 vaccines, and will contribute to the development of ExpreS2ion’s proprietary HER2-cVLP breast cancer vaccine, ES2B-C001. The OSAB will serve as advisors, potential contributors to the planned clinical studies and participants in Key Opinion Leader

The Nomination committee for Dicot AB appointed

Press release: Uppsala, November 3, 2022. According to decision at the Annual General Meeting of Dicot AB on May 24, 2022, the Nomination committee for the Annual General Meeting on May 23, 2023, shall consist of three members representing the three largest shareholders as of the end of September 2022.Based on the above, the Nomination committee for the 2023 Annual General Meeting (AGM) has been appointed with the following three members: · Bertil Lindkvist · Tore Robertsson · Arne Paalberg The Nomination committee shall submit proposals for decisions regarding the following

BioStock: Cyxone reports Q3 and presents T20K

Malmö-based Cyxone recently published its report for the third quarter, which testifies that the company is focusing on the phase IIb study with Rabeximod in rheumatoid arthritis. At the same time as the release of the report, the latest advances in the T20K program were presented at a scientific conference in the Netherlands. BioStock contacted acting CEO Carl-Magnus Högerkorp for an update.Read the full article at biostock.se: https://www.biostock.se/en/2022/11/cyxone-reports-q3-and-presents-t20k/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.

Bawat Water Technologies AB: BAWAT Announces Q3 Report 2022

Hørsholm, Denmark, November 3, 2022 – Bawat Water Technologies AB (BAWAT) today announces its Q3 Report for 2022. The report is available on Bawat’s website (investor.bawat.com)BAWAT is a leading supplier of sustainable ballast water treatment technology and services. BAWAT was listed on Nasdaq First North Premier Growth Market in Stockholm in March 2022.  Financial Highlights Q3 2022 – Expected lift in margin and Order Intake on the rise · Order intake in the third quarter was SEK 7.6m and currently Order Intake for the year is SEK 16.9m. · For the full year 2022, order intake

Invitation to the presentation and Q&A of the interim report

On the 10th of November at 10:00 CET, Speqta will present the interim report for Q3 2022 for shareholders, media and other stakeholders. Participants will be able to follow the presentation via webcast. CEO Fredrik Lindros and CFO Adam Jonsson will present the report, which will be followed by a Q&A session. There will be opportunities to ask questions via the webcast. The interim report will be released on November 10 at 07:00 CET. Time: Thursday November 10, 10:00–11:00 CET.Link to the webcast: https://www.redeye.se/events/847779/live-q-speqta-7 We look forward to

Exel Composites' financial calendar and Annual General Meeting in 2023

EXEL COMPOSITES PLC      STOCK EXCHANGE RELEASE      3 NOVEMBER 2022 at 11:00 EETExel Composites will publish the following financial reports in 2023: • Financial Statements Release 2022: 17 February 2023 at approximately 9:00 EET • Business Review Q1 2023: 2 May 2023 at approximately 9:00 EET • Half Year Financial Report Q1-Q2 2023: 18 August 2023 at approximately 9:00 EET • Business Review Q1-Q3 2023: 3 November 2023 at approximately 9:00 EET Annual Financial Report, including the Report of the Board the Directors as well as the financial statements, Corporate Governance

TORM plc to announce third quarter 2022 results

TORM plc (“TORM”) (ticker: TRMD A on Nasdaq in Copenhagen and TRMD on Nasdaq in New York) will release its financial results for the third quarter and nine months of 2022 on Thursday, 10 November 2022. TORM’s results will be presented on a live webcast via TORM’s website at 09:00 am Eastern Time / 03:00 pm Central European Time. Participants should register approximately ten minutes prior to the event. There will be a simultaneous conference call. For participation in the call, please dial +45 3271 4988 (or +1 (760) 294 1674 for US connections) at least ten minutes prior to the start

Stendörren acquires a warehouse asset in the Copenhagen region for SEK 69 million

Press release 3 November 2022 Stendörren Fastigheter AB (publ) has acquired the warehouse asset Svalehøjvej 17 in Ølstykke, from a private seller. The total property value is DKK 48 million, corresponding to circa SEK 69 million, and the total lettable area is 5 325 sq m. The asset is fully let to one tenant on a ten-year lease. Post the acquisition Stendörren’s portfolio in the Copenhagen region amounts to ten assets with a total lettable area of circa 36 000 sq m. The closing is expected to take place on the 1st of December 2022. For more information, please contact:

CO2 Capsol secures first debt financing through “green loan” for CapsolGo™ units

Oslo, Norway 03 November 2022CO2 Capsol AS has entered into a loan agreement with the Norwegian bank DNB forfinancing of CapsolGo™ unit 1 and unit 2. This is a “green loan” facility of23,000,000 NOK.“With this facility the company has strengthened its financial position andimproved its growth capacity,” says Ingar Berg, Chief Financial Officer at CO2Capsol.In October, CO2 Capsol announced start of operations on its CapsolGo™ unit 1 atÖstersundskraft’s Energy-from-Waste plant in Helsingborg, Sweden. Due to strongdemand from the European market, the company has invested in a

DanCann Pharma A/S signs binding agreement with Polish company Storkpharm worth more than DKK 40 million

COPENHAGEN, Denmark, November 3, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the Company has signed a supply agreement (the “Agreement”) with Storkpharm Sp. z o.o. (“Storkpharm”) for the Polish market. The Agreement covers the period 2024 to 2025 (the “Period”), and furthermore 2026 to be discussed during the Period.Storkpharm is a private hold pharmaceutical wholesale company in Poland, approved by Polish health authorities and with a widespread distribution network in the country that includes

BioStock: Arcede Pharma share under pressure despite development progress

Lund-based Arcede Pharma has had a tough start to its journey as a listed company after the spin-off from Respiratorius this summer. The ice cold stock market environment has weighed on the company’s shares. At the time of writing, the share is trading at well below Arcede Pharma’s cash position, despite the fact that the development is going according to plan. Here, BioStock looks closer at how the market values the potential that the company believes is present in the research.Read the full article at biostock.se: https://www.biostock.se/en/2022/11/arcede-pharma-share-under-pressure-

NanoCap Group AB net asset value for October 2022 - SEK 47 per share

Stockholm, 2022-11-03 NanoCap’s net asset value* 2022-10-31 SEK 197 million SEK 47 per share 2022-09-30 SEK 197 million SEK 47 per share 2022-08-31 SEK 233 million SEK 56 per share 2022-07-31 SEK 236 million SEK 57 per share 2022-06-30 SEK 262 million SEK 63 per share 2022-05-31 SEK 259 million SEK 62 per share 2022-04-30 SEK 257 million SEK 62 per share 2022-03-31 SEK 309 million SEK 74 per share 2022-02-28 SEK 284 million SEK 68 per share 2022-01-31 SEK 311 million SEK 75 per share 2021-12-31 SEK 340 million SEK 82 per share 2021-11-30 SEK 321

Interim Report Q3, 2022 - Ayima Group AB

Q3 Jul - Sep 2022 · Total Revenue amounted to 37.7 MSEK (42.9), a decrease of 12% from the corresponding period in 2021 · Gross Profit amounted to 22.2 MSEK (21.9), an increase of 2% from the corresponding period in 2021 · Gross Margin for the quarter increased from 51% in 2021 to 59% in 2022 · Operating costs amounted to 20.5 MSEK (17.2), an increase of 19% from the corresponding period last year · A positive EBITDA result of 1.7 MSEK (4.7) · Net Profit after tax for the period was -2.1 MSEK (1.5) YTD: Jan - Sep 2022 · Total Revenue amounted to 110.9

Snickers Workwear and the OrganoClick brand OrganoTex, launch a PFAS-free, biodegradable textile waterproofing for workwear in Europe

Snickers Workwear and the Swedish company OrganoClick are embarking on an international collaboration, jointly launching a wash-in textile waterproofing for workwear. The product will be sold under the Snickers Workwear brand, with a clear link to the OrganoClick brand OrganoTex. It will be available at Snickers Workwear retailers in Europe beginning in November 2022. “Our vision is to be at the leading edge of sustainability,” says Maria Schartau, CSR Coordinator for Snickers Workwear. “OrganoTex is a world-leading, PFAS-free, biodegradable textile waterproofing, so working with

Significant water conservation initiatives to be implemented along the Baltic Sea coast thanks to Catena

Logistics property company Catena is in the process of completing the financing of a water conservation project in which two coastal wetlands and two coastal estuaries are to be restored to create better spawning environments for fish.3 November 2022, 09.00 CEST   The aim of the ‘Fyra åtgärder för mer Östersjöfisk’ (Four measures for more Baltic Sea fish) project is to improve stocks of pike, perch and trout along the Baltic Sea coast, with the additional benefits of a healthier coastal environment with a rich biodiversity and more pleasant outdoor environments. The Penningby and

Neste and travel organization Sunweb Group announce partnership to reduce Sunweb customers’ flight emissions with sustainable aviation fuel

Neste Corporation, Press Release, 3 November 2022 at 10.00 a.m. (EET)Sunweb Group, one of the leading European travel organizations, and Neste announce today that they have entered into a new partnership based on which Sunweb Group purchases 306 tons (385,000 liters) of Neste MY Sustainable Aviation Fuel™  (SAF) from Neste to reduce greenhouse gas (GHG) emissions resulting from Sunweb flights. The SAF volume purchased provides an emission reduction equaling the amount of GHG emissions from all Sunweb flights departing in

Terveystalo Plc: Managers’ Transactions (Kauniskangas)

Terveystalo Plc, Managers’ transactions, 3 November 2022 at 10:00 EET On 7 April 2022, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

Terveystalo Plc: Managers’ Transactions (Rosenberg)

Terveystalo Plc, Managers’ transactions, 3 November 2022 at 10:00 EET On 7 April 2022, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

The Fascinating World of Facades

Outstanding architectural projects at the 6th International NEXT Facade Summit With the 6th edition of the successful International NEXT Facade Summit format, everything in WICONA + Partners' NEXT Studio in Frankfurt revolves around the motto "Think Globally, Build Locally". Starting at 4 pm (CET) on November 15, 2022, experts from internationally renowned architecture and planning offices will report on innovative and sustainable facade or building projects in an international context. The English-language event will be live-streamed. Architecture that prioritizes people

Viaplay, Eleventh Hour Films and Ian Rankin partner for a major ‘Rebus’ reimagining

· Acclaimed screenwriter Gregory Burke to create and write premium drama series based on Ian Rankin’s internationally bestselling Rebus detective books, with Burke and Rankin serving as Executive Producers · Six-part series is Viaplay Group’s initial UK drama commission and the first Rebus TV adaptation for nearly 15 years · Viaplay launched in the UK on 1 November Viaplay, Eleventh Hour Films and the internationally bestselling author Ian Rankin will partner for a major reimagining of Rankin’s iconic detective, Inspector John Rebus, drawn from the instantly recognisable universe

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT OCTOBER 2022

Zinzino group revenue increased with a total of 22%, compared with the previous year. The revenue in October for Zinzino's sales markets increased by 22% and amounted to SEK 125.4 (102.4) million. Faun Pharma's external sales increased by 12% and amounted to SEK 4.8 (4.3) million. Overall, the Group increased revenues by 22% to SEK 130.2 (106.7) million compared with the previous year. Accumulated revenue for January – October 2022 increased by 6% to SEK 1144.0 (1076.1) million. Revenues were distributed as follows: Regions, mSEK 22-Oct 21-Oct Change YTD 2022 YTD 2021

Terveystalo Plc: Managers’ Transactions (Viippola)

Terveystalo Plc, Managers’ transactions, 3 November 2022 at 10:00 EET On 7 April 2022, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

Terveystalo Plc: Managers’ Transactions (Pullola)

Terveystalo Plc, Managers’ transactions, 3 November 2022 at 10:00 EET On 7 April 2022, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

Terveystalo Plc: Managers’ Transactions (Lemne)

Terveystalo Plc, Managers’ transactions, 3 November 2022 at 10:00 EET On 7 April 2022, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in the Company's shares, which will be purchased from the market on behalf of the members of the Board of Directors at a price determined in public trading, and 60% is paid in cash. Annual General Meeting also resolved that the shares will be purchased within a period of two weeks beginning

There are no items matching the current filter
There are no more items matching the current filter
Back to top